/5
0 avis
Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma.
Archive ouverte
Edité par CCSD ; American Society of Clinical Oncology -
International audience
Consulter en ligne
Chargement des enrichissements...